The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.02% higher by 4.5 points at 22,554.5, indicating that the domestic benchmark indices are likely to make a positive start on Thursday.
On Wednesday, 12 March, Domestic benchmark indices S&P BSE Sensex slipped by 73 points or 0.10% and settled at 74,030 while the Nifty50 traded 0.12% lower by 27 points, settling at 22,470.
Here are some stocks that are likely to remain in focus on 13 March.
BEML: The company has announced signing two Memorandum of Understanding (MoUs) with Siemens, India, to increase its presence in the rail and dredging sectors. As a part of the agreement, the company will jointly explore opportunities in the suburban passenger train and semi-high-speed segment, along with metro and commuter rail markets.Â
Bharat Electronics: The company has announced signing a contract with the Ministry of Defence worth Rs 2,463 crore. The contract is for the supply and services of Ashwini radars to the Indian Air Force.
Jubilant Pharmova: The company’s subsidiary Jubilant Cadista Pharmaceuticals Inc. has announced securing an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the US Food and Drug Administration (USFDA) for its solid oral unit in Salisbury, Maryland.
NTPC Green Energy: The company has announced the successful commissioning of the second and final part of the 50 MW capacity from the 105 MW Shajapur Solar Project (Unit-1) of its subsidiary, NTPC Renewable Energy. Â
Swelect Energy Systems: The company has announced securing orders for 150 megawatts (MW) for its TOPCon Bi-facial solar PV modules. Moreover, the Swelect Group has also raised Rs 290 crore in funding through non-convertible debentures (NCDs) through a private placement with India Infradebt.Â
Zydus Lifesciences: The company’s venture capital subsidiary, Zynext Ventures USA LLC, has announced its investment in bio-pharmaceutical company Illexcor Therapeutics. This investment highlights Zynext Ventures’ commitment to supporting disruptive healthcare innovations that address significant unmet medical needs.
Coromandel International: The company has announced signing a definitive agreement to acquire a 53% stake in NACL Industries at Rs 76.7 per share, taking the total transaction to Rs 820 crore. The shares of the company will be acquired from the company’s current promoter, KLR Products.
The future of investing is here!
Unicorn Signals leverages advanced AI technology to provide you with powerful market predictions and actionable stock scans. Download the app todayand 10x your trading & investing journey!